Gardner Center for Parkinson's Disease

and Movement Disorders

234 Goodman Street, Cincinnati, Ohio 45219 | (866) 941-UCNI (8264)

Study Seeks to Identify Parkinson's Biomarkers

Thursday, February 9, 2012
Contact: 
Keith Herrell
(513) 558-4559
keith.herrell@uc.edu



CINCINNATI—A landmark clinical study called the Parkinson’s Progression Markers Initiative (PPMI) will seek to identify biomarkers of Parkinson’s disease progression—and also provide a chance for volunteers to help in the fight against Parkinson’s.

The James J. and Joan A. Gardner Center for Parkinson’s Disease and Movement Disorders at the University of Cincinnati (UC) Neuroscience Institute is participating in the study and is currently accepting volunteers. The Gardner Center, directed by Fredy J. Revilla, MD, an associate professor of neurology at UC, is one of nine centers within the UC Neuroscience Institute, a specialty institute within UC Health.

Learn more >>

* * *


The UC Neuroscience Institute, a regional center of excellence, is dedicated to patient care, research, education, and the development of new treatments for stroke, brain and spinal tumors, epilepsy, traumatic brain and spinal injury, Alzheimer’s disease, Parkinson’s disease, multiple sclerosis, disorders of the senses (swallowing, voice, hearing, pain, taste and smell), and psychiatric conditions (bipolar disorder, schizophrenia, and depression).